secwatch.observer — SEC 8-K summary
======================================

Issuer:     AGIOS PHARMACEUTICALS, INC. (AGIO)
CIK:        0001439222
Form:       8-K
Filed at:   2022-06-22T23:59:59+00:00
Accession:  0001193125-22-178757
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Agios shareholders elect directors, approve say-on-pay, ratify PwC at 2022 annual meeting
--------------------------------------------------------------------------------

- Elected Jacqualyn A. Fouse, David Scadden, David P. Schenkein as class III directors (48.5M, 48.5M, 45.4M votes for).
- Advisory vote on executive compensation approved: 45.0M for, 4.5M against, 9K abstain.
- Shareholders recommended say-on-pay every 1 year (48.7M votes); Board adopts annual frequency.
- Ratified PricewaterhouseCoopers LLP as independent auditor for fiscal 2022: 50.6M for, 140K against.
- Broker non-votes of 1.17M on director elections and advisory items.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1439222/000119312522178757/0001193125-22-178757-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1439222/000119312522178757/d342593d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-178757

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer